Exhaled nitric oxide levels and airway responsiveness to adenosine 5′-monophosphate in subjects with nasal polyposis

International Archives of Allergy and Immunology

Volumn 134, Issue 4, 2004, Pages 303-309

  Prieto, L ^a   Seijas, T ^a   Gutierrez V ^a   Uixera, S ^a   Brunoa R Lopez L ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Adenosine 5 monophosphate; Airway responsiveness; Methacholine; Nasal polyposis; Nitric oxide

Indexed keywords

ADENOSINE PHOSPHATE; METHACHOLINE; NITRIC OXIDE;

ADULT; AIRWAY; ARTICLE; ASTHMA; ATOPY; BRONCHOSPASM; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; CONTROLLED STUDY; EXHALATION; EXPIRED AIR; FEMALE; GEOMETRY; HUMAN; INHALATION; MALE; MEASUREMENT; NOSE POLYP; PATIENT; PRIORITY JOURNAL; PROVOCATION TEST;

ADENOSINE MONOPHOSPHATE; ADULT; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; BRONCHOCONSTRICTOR AGENTS; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; METHACHOLINE CHLORIDE; NASAL POLYPS; NITRIC OXIDE; STATISTICS;

EID: 4043146462     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079168     Document Type: Article

References (37)

1. Wladislavosky-Waserman P, Kern EB, Holley KE, Eisenberg AB, Gleich GJ: Epithelial damage in nasal polyps. Clin Allergy 1984;14:241-247.
2. Larsen K: The clinical relationship of nasal polyps to asthma. Allergy Asthma Proc 1996;17:243-249.
3. Lamblin C, Gosset P, Salez F, Vandezande LM, Perez T, Darras J, Janin A, Tonnel AB, Wallaert B: Eosinophilic airway inflammation in nasal polyposis. J Allergy Clin Immunol 1999;104:85-92.
4. Lamblin C, Bolard F, Gosset P, Tsicopoulos A, Perez T, Darras J, Janin A, Tonnel AB, Hamid Q, Wallaert B: Bronchial interleukin-5 and eotaxin expression in nasal polyposis. Relationship with (a)symptomatic bronchial hyperresponsiveness. Am J Respir Crit Care Med 2001;163:1226-1231.
5. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE: Bronchial reactivity to inhaled histamine: A method and clinical survey. Clin Allergy 1977;7:235-243.
6. Björck T, Gustafsson LE, Dahlen SE: Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. Am Rev Respir Dis 1982;145:1087-1091.
7. Polosa R, Ng WH, Crimi N, Vancheri C, Holgate ST, Church MK, Mistreta D: Release of mast-cell-derived mediators after endobronchial adenosine challenge in asthma. Am J Respir Crit Care Med 1995;151:624-629.
8. Jacobs RL, Freda AJ, Culver WB: Primary nasal polyposis. Ann. Allergy 1983;51:500-505.
9. Miles-Lawrence R, Kaplan M, Chung K: Methacholine sensitivity in nasal polyposis and the effect of polypectomy (abstract). J Allergy Clin Immunol 1982;69:102.
10. Lamblin C, Tillie-Leblond I, Darras J, Dubrulle F, Chevalier D, Cardot E, Perez T, Wallaert B, Piquet TJ, Tonnel AB: Sequential evaluation of pulmonary function and bronchial hyperresponsiveness in patients with nasal polyposis. A prospective study. Am J Respir Crit Care Med 1997;155:99-103.
11. Alving K, Weitzberg E, Lundberg JM: Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993;6:1368-1370.
12. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ: Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994;343:133-135.
13. Crater SE, Peters EJ, Martin ML, Murphy AW, Platts-Mills TAE: Expired nitric oxide and airway obstruction in asthma patients with an acute exacerbation. Am J Respir Crit Care Med 1999;159:806-811.
14. Jatakanon A, Kharitonov S, Lim S, Barnes PJ: Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax 1999;54:108-114.
15. Kharitonov SA, Yates DH, Barnes PJ: Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996;153:454-457.
16. Kharitonov SA, Yates DH, Chang KF, Barnes PJ: Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 1996;9:196-201.
17. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ: Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998;53:91-95.
18. Barnes PJ, Kharitonov SA: Exhaled nitric oxide: A new lung function test. Thorax 1996;51:233-237.
19. American Thoracic Society: Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. Am J Respir Crit Care Med 1999;160:2104-2117.
20. Martin V, Bryden K, Devoy M, Howarth P: Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis. J Allergy Clin Immunol 1996;97:768-772.
21. Henriksen AH, Sue-Chu M, Holmen TL, Longhammer A, Bjermer L: Exhaled and nasal NO levels in allergic rhinitis: relationship to sensitization, pollen season and bronchial hyperresponsiveness. Eur Respir J 1999;13:301-306.
22. Gratziou Ch, Lignos M, Dassion M, Roussos Ch: Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis. Eur Respir J 1999;14:897-901.
23. Prieto L, Gutiérrez V, Uixera S: Exhaled nitric oxide and bronchial responsiveness to adenosine 5′-monophosphate in subjects with allergic rhinitis. Chest 2002;121:1853-1959.
24. Horvath I, Barnes PJ: Exhaled monoxides in asymptomatic atopic subjects. Clin Exp Allergy 1999;29:1276-1280.
25. American Thoracic Society: Standardization of spirometry-1987 update. Am Rev Respir Dis 1987;136:1285-1294.
26. Quanjer PH (ed): Standardized lung function testing. Bull. Eur Physiopathol. Respir 1983;19(suppl 5):1-95.
27. Chai H, Farr RS, Froehlich LA, Mathison DA, McLean JA, Rosenthal RR, Sheffer AL, Spector SL, Townley RG: Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323-327.
28. American Thoracic Society: Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 2000;161:309-329.
29. Prieto L, Marín J: Methacholine inhalation challenge. Practical consequences of using duplicate spirogram after each concentration. Ann. Allergy 1993;70:487-490.
30. Prieto L, Gutiérrez V, Liñana J, Marín J: Bronchoconstriction induced by inhaled adenosine 5′-monophosphate in subjects with allergic rhinitis. Eur Respir J 2001;17:64-70.
31. Prieto L, Gutiérrez V, Marín J: Relationship between airway sensitivity to adenosine 5′-monophosphate and the shape of the concentration-response curve to methacholine in subjects with allergic rhinitis. Respir Med 2001;95:457-463.
32. Pauwels R, Joos G, van der Straeten M: Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not bronchial asthma. Clin Allergy 10988;18:317-321.
33. Polosa R, Lau LCK, Holgate ST: Inhibition of adenosine 5′-monophosphate- and methacholine-induced bronchoconstriction in asthma by inhaled frusemide. Eur Respir J 1990;3:665-671.
34. Moreno RH, Hogg JC, Paré PD: Mechanics of airway narrowing. Am Rev Respir Dis. 1986;133:1171-1180.
35. Silkoff PE, McClean PA, Slutsky AS, Furlatt HG, Hoffstein E, Wakita S, Chapman KR, Szalai JP, Zamel N: Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med 1997;155:260-267.
36. Arnal JF, Flores P, Rami J, Murris-Espin M, Bremont F, Aguilla MPI, Serrano E, Didier A: Nasal nitric oxide concentration in paranasal sinus inflammatory diseases. Eur Respir J 1999;13:307-312.
37. Kordash TR, Gleich GJ, Kern EB, O'Fallon WM: Evidence for increased risk of development of asthma in patients with nasal polyps (abstract). J Allergy Clin Immunol 1978;11:138.